Arrowstreet Capital Limited Partnership Sells 27,818 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Arrowstreet Capital Limited Partnership trimmed its position in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 6.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 403,412 shares of the biotechnology company’s stock after selling 27,818 shares during the quarter. Arrowstreet Capital Limited […]